MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway.

Bioscience Reports
Ying YangYongxing Bao

Abstract

MicroRNAs (miRNAs) play an important role in drug resistance, and it is reported that miR-27a-3p regulated the sensitivity of cisplatin in breast cancer, lung cancer and ovarian cancer. However, the relationship between miR-27a-3p and chemosensitivity of cisplatin in hepatocellular carcinoma (HCC) was unclear, especially the underlying mechanism was unknown. In the present study, we analyzed miR-27a-3p expression levels in 372 tumor tissues and 49 adjacent tissues in HCC samples from TCGA database, and found that the miR-27a-3p was down-regulated in HCC tissues. The level of miR-27a-3p was associated with metastasis, Child-Pugh grade and race. MiR-27a-3p was regarded as a favorable prognosis indicator for HCC patients. Then, miR-27a-3p was overexpressed in HepG2 cell, and was knocked down in PLC cell. Next, we conducted a series of in vitro assays, including MTT, apoptosis and cell cycle assays to observe the biological changes. Further, inhibitor rate and apoptosis rate were detected with pre- and post-cisplatin treatment in HCC. The results showed that overexpression of miR-27a-3p repressed the cell viability, promoted apoptosis and increased the percentage of cells in G0/G1 phase. Importantly, overexpression of miR-27a-3p si...Continue Reading

References

Nov 10, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hiroaki TakahashiMasao Hosokawa
May 7, 2011·Critical Reviews in Oncology/hematology·Elisa GiovannettiGodefridus J Peters
Aug 1, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Keijiro SugimuraYuichiro Doki
Dec 21, 2012·International Journal of Oncology·Weiyi XuSongshan Jiang
Oct 2, 2013·Annual Review of Pathology·Gianpiero Di LevaCarlo M Croce
Mar 29, 2014·European Journal of Internal Medicine·Dirk GrafDieter Häussinger
Dec 4, 2014·Obstetrics & Gynecology Science·Hyun Gyo LeeChi Heum Cho
Jan 21, 2015·Current Molecular Medicine·V Dimitrova, A Arcaro
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Dec 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Sumei ZhouXiaohua Zhang
Mar 16, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Wei MengGuihua Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis